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Abstract
Background: Trauma is still the leading cause of death in many regions of the world. Severity scores have been
developed to assist in management of trauma victims. Immune response to trauma has been known to positively
correspond to the severity of trauma. Part of this response involves release of cytokines into blood circulation which
promote the acute inflammatory response commonly seen after trauma. Studies have shown that IL-6 levels
commonly correlate positively with the Injury Severity Score (ISS). The aim of this cross-sectional study was to
determine whether this kind of relationship exists between IL-6 levels and injury severity in trauma patients in
Mulago Hospital as defined by the Kampala Trauma Score (KTSII) which is locally developed.
Methods: Trauma patients aged ≥18 years presenting to the Accident and Emergency unit of Mulago National
Referral Hospital (MNRH) within 12 h after injury were recruited into the study after obtaining consent. Severity of
injury was determined as per the Kampala Trauma Score (KTSII) and venous blood drawn for assay of serum IL-6
levels. Data obtained was entered and analyzed using Stata version 11 software focusing on the association between
Serum IL-6 levels with Severity of trauma and duration of injury.
Results: A total of 159 patients were recruited (79 Mild and 80 Severe trauma) with a male to female ratio of 4.7:1.
Road traffic crashes (67.92 %) were the commonest cause of injury. Serum IL-6 levels were found to positively
correspond with severity of injury (z = 4.718, p < 0.001). There was no significant correlation between serum IL-6
levels and duration of injury in both severe (r = 0.12, p = 0.29) and mild (r = 0.06, p = 0.62) trauma groups of patients.
Only 9.43 % of trauma patients were brought in an Ambulance.
Conclusions: Serum IL-6 levels correspond with severity of injury. However, within the first twelve hours after injury,
these levels did not vary significantly with duration of injury.
Keywords: Interleukin-6, Kampala Trauma Score II, Duration of injury
Background
Trauma remains the leading cause of death globally hence
its public health significance. It affects mainly the young
and most economically productive age groups [1–3].
This burden and death rates are higher in Africa than
Europe due to factors like poor road designs and poor
mechanical condition of motor vehicles [4]. In Uganda,
trauma is the single most common reason for admission
to surgical wards [5–7], affecting mainly the young popu-
lation [8, 9].
Many severity scores have been developed to help in tri-
age, management and prediction of outcome in trauma pa-
tients [10–12]. These scores are based on anatomical or
physiological parameters or both. Immune response to in-
jury as determined by circulating levels of serum IL-6 have
been found to correspond to severity of injury as defined by
the Injury Severity Score [13–16].
Damage associated molecular patterns (DAMPs) and
alarmins trigger the immune response to trauma and/or
burns in humans [17]. Xiao et al. [18] described this
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increased gene expression and alteration of up to 80 % of
the leukocyte transcriptome. The magnitude of the storm
was found to be directly proportional to the frequency and
severity of complications. It is now known that both pro
and anti-inflammatory responses occur simultaneously as
previously suggested by Xiao et al. [18] and are associated
with injury severity and outcome [19].
These findings support the current paradigm shift
towards use of biochemical/immunological markers in
injury severity scoring [20] since many previous scores argu-
ably depend on subjective anatomical and physiological pa-
rameters. Interleukin 6 is preferred because of its long
duration of detectability in blood, independence of kidney
function and availability of rapid measurement systems [21].
The aim of this study was to determine the association
between serum IL-6 levels and injury severity as defined
by the Kampala Trauma Score (KTS) II, a locally devel-
oped severity score tool in an Urban, low-income setting
and describe the association between these levels and
duration of injury.
Methods
This was a cross-sectional study carried out at Mulago
National Referral Hospital (MNRH) over a period of
2 months from January to February 2014.
Study setting
The study was carried out at the Accident and Emergency
(A&E) unit of MNRH which is headed by a consultant sur-
geon. This department handles both medical and surgical
emergencies in separate wings. It has two operating rooms,
an X-ray and Ultrasound facility, two resuscitation rooms,
two mechanical ventilators and a twenty six bed holding
emergency ward. Next to the department are a blood bank,
haematology, microbiology and chemistry laboratories.
Study participants
All trauma patients aged ≥18 years presenting or re-
ferred within 12 h of injury to MNRH were eligible for
the study. Patients who from history or assessment
were found to be on steroid therapy, asthmatic, or
have diabetes mellitus or rheumatoid arthritis were ex-
cluded because these conditions affect serum IL-6
levels. Using the KTS II, patients were divided into
two groups: severe injury (KTS II ≤8) and mild injury
(KTS II >8).
Consecutive sampling was used for the severely in-
jured group as opposed to systematic random sampling
for the mildly injured group. The A&E department re-
ceives twenty two mildly injured patients per day (range
15 – 30). Study participants were recruited four days per
week and with a study period of 2 months; every ninth
mildly injured patient was consented and recruited into
the study.
Study procedure
On arrival patients were assessed based on the Advanced
Trauma Life Support (ATLS) principles and scored using
the KTS II. Consenting patients had variables age, sex,
mode of arrival, duration of injury (time in hours from
injury to time blood sample was drawn for analysis of
serum IL-6 levels), type of injury, cause of injury and
body region injured recorded.
Under aseptic technique, 4mls of venous blood was
drawn from a convenient peripheral vein, centrifuged at
1000 r.p.m and the serum layer was removed and stored
at -80 °C at the Makerere University College of Health
Sciences Immunology Laboratory. Serum assay for IL-6
levels were run at the end of the study period using
Human IL-6 ELISA kit supplied by Biolegend [22].
Repeated freeze-thaw cycles were avoided as recom-
mended by the manufacturer.
The Kampala Trauma Score
The most widely used injury scores are the ISS, Trauma
Injury Severity Score (TRISS) and the RTS. These inter-
national scores are however very demanding and require
detailed data collection and an analysis of accurate pro-
spectively collected data. In 1996 the Injury Control
Centre-Uganda (ICC-U) developed the Kampala Trauma
Score I (KTSI) as a simplified version and composite of
both the ISS and RTS so that it could be used by all
health cadres in resource limited centers. In 2004, the
score was revised from the initial 16-point scale to the
current 10-point scale which is simpler to use. This re-
vised version is now referred to as the KTSII. The KTSII
considers and scores five parameters in patients’ assess-
ment: age (in years), respiratory rate, systolic blood pres-
sure, neurologic status and score for serious injuries on
admission [Table 1]. Mild, moderate and severe injuries
are designated scores 9 – 10, 7 – 8 and ≤6 respectively.
The KTS has previously been validated and found to
compare favorably with other trauma scores [7, 23–26].
Ethical approval
Ethical approval was obtained from the department of
surgery MNRH and the Institutional Review Board of
Makerere University College of Health Sciences – School
of Medicine. Written informed consent was sought from
participants or their next of kin.
Data analysis
Data were analyzed using Stata version 11. Descriptive
analyses were presented using scatter plots, box plots
and bar graphs. Summary statistics were presented using
percentages for categorical variables, and median and
interquartile ranges for continuous variables. Transform-
ation methods were used for non-normally distributed
data. The Mann-Whitney U test was used to assess for
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differences in IL-6 level between severe trauma and mild
trauma. We log transformed both the IL-6 level and dur-
ation of injury to achieve a linear relationship. Pearson’s
correlation coefficient r was used to assess the relation-
ship of log transformed IL-6 and log transformed dur-
ation of injury. A one sided 2.5 % significance level was
used for all analyses. Determination of sensitivity and
specificity of serum IL-6 levels in stratifying patients by
severity of trauma using the KTSII as gold standard was
done. The cut off on serum IL-6 level was varied by
50 pg upwards starting from 1.00 pg and computed sen-
sitivity and specificity at each level. Using the sensitivity
and specificity scores, a receiver operator characteristic
(ROC) curve was generated.
Results
A total of 159 patients (79 mild injury and 80 severe
injuries) were recruited into the study. Male to Female
ratio was 4.7:1. Of the study participants, 42.14 % had
studied up to primary school level and 11.32 % had no
formal education [Table 2]. Only 9.43 % were brought in
an Ambulance.
The most commonly injured body region was head
and neck [Table 3], accounting for 51.57 % of the study
population. Road traffic crash was the commonest cause
of injury accounting for 67.92 % and of these 45.37 %
were pedestrians.
There was a significant distribution of serum IL-6
levels among the severely injured and mildly injured
groups of patients (z = 4.718, p < 0.001) [Fig. 1]. The area
under receiver operator curve was 0.6975 (95 % CI 0.616 –
0.778) [Fig. 2]. At a cut off of 60 pg/ml, serum IL-6 levels
were able to discriminate between mild and severe injury
with a sensitivity of 77.63 % and specificity of 50.00 % with
a Positive Predictive value of 60.82 and Negative Predict-
ive value of 69.09.
The median duration of injury in severely injured
patients was 3.5 (1.5-6.0) hours while that in the mildly
injured group was 3.0 (1.25-4.5) hours. There was no
significant correlation between serum IL-6 levels with
duration of injury (severe group r = 0.12, p = 0.29 and
mild group r = 0.06, p = 0.62) [Fig. 3].
Discussion
The aim of this study was to describe the association be-
tween serum IL-6 levels and severity of injury as defined
by the KTS II. Severe trauma included a KTS II score of
≤8 while Mild trauma included a KTS II score of >8.
We found a significant distribution of serum IL-6
levels among the severe and mildly injured groups of pa-
tients (z = 4.718, p < 0.001). Patients with severe trauma
had a higher rank (Mann-Whitney test). Even when the
Table 1 The Kampala Trauma Score II
Description Score
A Age (in years)
5-55 1
<5 or >55 0
B Systolic Blood Pressure on admission
More than 89 mm Hg 2
Between 89-50 mm Hg 1
Equal or below 49 mm Hg 0
C Respiratory rate on admission
0-29/minute 2
30+ 1
< or =9/minutes 0
D Neurological status
Alert 3
Responds to verbal stimuli 2
Responds to painful stimuli 1
Unresponsive 0
E Score for serious injuries
None 2
One injury 1
More than one 0
Kampala Trauma Score total = A + B + C + D + E
Table 2 Sociodemographic characteristics of study population
by severity of trauma among trauma patients attending Mulago
Hospital
Characteristic Severe trauma Mild trauma P-value
N = 80 N = 79
Age, median(IQR) 27 (24-37) 27 (23-35) 0.70
Gender, n (%)
Male 67 (83.75) 64 (81.01) 0.65
Education level, n (%)
No formal Education 11 (13.75) 7 (8.86) 0.004
Primary 31 (38.75) 36 (45.57)
Secondary 21 (26.25) 31 (39.24)
Tertiary 5 (6.25) 5 (6.29)
Occupation, n (%)
Peasant 14 (17.50) 11 (13.92) 0.007
Business 28 (35.00) 33 (41.77)
Salaried/wage earner 22 (27.50) 30 (37.97)
Student 4 (5.00) 5 (6.33)
Transport to Hospital, n (%)
Ambulance 9 (11.25) 6 (7.59) 0.001
Police pickup 43 (53.75) 23 (29.11)
Boda boda 3 (3.75) 18 (22.78)
Ordinary(private/public) car 25 (31.25) 30 (37.97)
Other 0 (0.00) 2 (2.53)
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KTS II was broken down to its three original categories
of mild, moderate and severe trauma, serum IL-6 levels
were still noted to increase with increasing/worsening
severity of injury, showing that IL-6 levels in this study
were relatively able to group trauma patients into sever-
ity categories.
Interleukin 6 is a 26 kDa cytokine produced as part of
the human body’s immune response to trauma [27]. It is
released with 1 – 4 h following trauma and stays for a
few days before beginning to decline [28]. Its effects
include but are not limited to B cell maturation, differ-
entiation and activation, activation of Natural Killer cells
and release of soluble Tumor Necrosis Factor receptor
antagonist [27, 28]. These effects arise following inter-
action with IL-6 receptor system that is composed of a
ligand binding α-subunit (IL-6R) and a signal transdu-
cing β-subunit (gp130) [27]. It therefore has both pro
and anti-inflammatory effects much as it is grouped
under Th1 cytokines [29].
Controlled and balanced inflammatory response is
beneficial to the body. Excessive anti-inflammatory
response is thought to cause immunoparalysis and hence
worse outcomes. While measuring cytokines and adhe-
sion molecules in the first 72 h in severely injured
patients, Sousa et al. [19] found that serum IL-6 levels
correlated with injury severity and outcomes. In their
study, a low Th1/Th2 ratio was associated with worse
outcomes.
Table 3 Injury characteristics of study population by severity of






Body region injured, n (%)
Head and/or Neck 55 (68.75) 27 (34.18) <0.001
Face 15 (18.75) 19 (24.05) 0.45
Thorax 17 (21.25) 11 (13.92) 0.23
Abdomen/visceral pelvis 4 (5.00) 5 (6.33) 0.72
Extremities/bony pelvis 27 (33.75) 28 (35.44) 0.82
External (Skin) 30 (37.50) 30 (37.97) 0.95
Cause of injury, n (%)
Road traffic crush 57 (71.25) 51 (64.56) 0.14
Assault 19 (23.75) 15 (18.99)
Falls 3 (3.75) 10 (12.66)
Burns 1 (1.25) 3 (3.80)
Type of injury, n (%)
Penetrating 32 (40.00) 30 (37.97) 0.59
Blunt force 47 (58.75) 46 (58.23)
Burn 1 (1.25) 3 (3.80)
Role of crash victim, n (%)
Driver 14 (17.50) 13 (16.46) 0.36
Passenger 13 (16.25) 20 (25.32)









































Fig. 1 Distribution of IL-6 levels by severity of trauma among trauma patients attending Mulago Hospital. Panel a: Trauma categorized by KTS II
into Severe vs Moderate vs Mild trauma. Panel b: Trauma categorized into Severe (combined KTS II severe and moderate trauma) vs Mild trauma
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Numerous authors elsewhere have documented that
serum IL-6 levels positively correspond with severity of
injury [14, 19, 30–34].
The area under the ROC curve was only 0.6975, show-
ing that serum IL-6 levels were unable to significantly
discriminate between severe and mild injury. However,
at a cut off level of 60 pg/ml, serum IL-6 levels could
differentiate between severe and mild injury with a rela-
tively high sensitivity of 77.63 %. This is however higher
than sensitivity of 16.7 % of IL-6 for MODS that was
found by Frink et al. [35]. This difference could be
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Fig. 3 Scatter plots showing variation of IL-6 levels with duration of injury in hours in the Severe and Mild categories of trauma patients attending
Mulago Hospital. Panel a: IL-6 levels vs duration of injury in hours. Panel b: Correlation between IL-6 levels and duration of injury in hours after
Log transformation
Okeny et al. BMC Emergency Medicine  (2015) 15:22 Page 5 of 7
IL-6 cut off level of 60 pg/ml so as not to miss any
patient with severe injury.
Despite the fact that these studies used the ISS and
where done in high-income countries with a modern
health care system while we used the KTS II in a low-
income setting/population with a prevalence of malnu-
trition at 19 % [36], serum IL-6, an inflammatory
marker, was still found to positively correspond with
injury severity. It may also reiterate the fact that the
KTS II compares favorably with the ISS.
In this study, duration of injury of atleast 3 h is way
beyond the recommended ‘golden hour’ in trauma man-
agement. Therefore, patients with severe life threatening
injuries may have died before arrival at the emergency
unit leading to a selection bias. Similar durations were
reported in studies done in low-income settings [5, 8]
compared to less than 70 min in high income settings
[14, 37]. This could be due to a relatively poor Ambu-
lance system in our setting since only 9.43 % of trauma
patients arrived at the hospital in an Ambulance.
We did not find any significant correlation between
serum IL-6 levels and duration of injury as compared to
studies done elsewhere [14, 30]. This disparity could be
that these studies measured serial serum IL-6 levels in
each individual trauma patient as early as from the
scene of injury whereas in this study, we analyzed IL-6
levels in different individuals who reported at different
times to the hospital. Individuals may vary in the timing
and magnitude of their physiobiochemical response to
injury.
The median duration of injury in both trauma groups
were within the six hours of peak levels found by
Antunes et al. [32] and twelve hours of peak levels found
by Gebhard et al. [30]. This means that the rise in serum
IL-6 levels in this study population is probably only due
to severity of trauma and not variation in time from
injury to presentation.
Study limitations
Due to the study design, we are unable to completely
guarantee stability of serum IL-6 levels within the first
few hours after injury. The median duration of injury
(time to hospital), was 3 h. This brings in a selection bias
since patients with life threatening injuries may have
died within the first hour after injury.
Conclusions
Serum IL-6 levels correspond with severity of injury as
defined by the KTS II. Routine measurements of serum
IL-6 levels in all trauma patients may be negated by
costs in many centers. However, prognostic significance
of serum IL-6 levels in severely injured patients in low-
income settings needs to be investigated.
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